rofecoxib has been researched along with Dysmenorrhea in 11 studies
Dysmenorrhea: Painful menstruation.
Excerpt | Relevance | Reference |
---|---|---|
"To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea." | 9.10 | Dysmenorrhea treatment with a single daily dose of rofecoxib. ( Kurban, Y; Sahin, I; Saraçoğlu, F; Türkkani, B, 2003) |
"To determine whether rofecoxib is effective for treating primary dysmenorrhea and whether cyclooxygenase-2 is involved in the pathophysiology of primary dysmenorrhea." | 9.09 | Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. ( Cantu, N; Daniels, SE; Kotey, P; Morrison, BW; Seidenberg, B, 1999) |
"Rofecoxib and diclofenac potassium, when taken in recommended doses, were equally effective in alleviating pain associated with primary dysmenorrhea." | 5.13 | The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain. ( Chantler, I; Fuller, A; Mitchell, D, 2008) |
"To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea." | 5.10 | Dysmenorrhea treatment with a single daily dose of rofecoxib. ( Kurban, Y; Sahin, I; Saraçoğlu, F; Türkkani, B, 2003) |
"To determine whether rofecoxib is effective for treating primary dysmenorrhea and whether cyclooxygenase-2 is involved in the pathophysiology of primary dysmenorrhea." | 5.09 | Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. ( Cantu, N; Daniels, SE; Kotey, P; Morrison, BW; Seidenberg, B, 1999) |
"Rofecoxib, used for dysmenorrhea, caused a herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand." | 3.71 | Fixed drug eruption to rofecoxib. ( Florentino, FT; Gilliam, AC; Nedorost, ST, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nedorost, ST | 1 |
Florentino, FT | 1 |
Gilliam, AC | 1 |
Sahin, I | 1 |
Saraçoğlu, F | 1 |
Kurban, Y | 1 |
Türkkani, B | 1 |
Bitner, M | 1 |
Kattenhorn, J | 1 |
Hatfield, C | 1 |
Gao, J | 1 |
Kellstein, D | 1 |
Yodfat, Y | 1 |
Chantler, I | 1 |
Mitchell, D | 1 |
Fuller, A | 1 |
Scott, LJ | 1 |
Lamb, HM | 1 |
Morrison, BW | 1 |
Daniels, SE | 1 |
Kotey, P | 1 |
Cantu, N | 1 |
Seidenberg, B | 1 |
Miller, JL | 1 |
Sirakov, M | 1 |
FitzGerald, GA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age[NCT02255045] | Phase 2/Phase 3 | 68 participants (Actual) | Interventional | 2014-06-27 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for rofecoxib and Dysmenorrhea
Article | Year |
---|---|
[Is there a future for COX-2 inhibitors?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 I | 2004 |
Rofecoxib.
Topics: Analgesics; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; En | 1999 |
[VIOXX--a new world without pain].
Topics: Adult; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Lactones; Pain; Sulfones | 2001 |
4 trials available for rofecoxib and Dysmenorrhea
Article | Year |
---|---|
Dysmenorrhea treatment with a single daily dose of rofecoxib.
Topics: Administration, Oral; Adult; Analysis of Variance; Chi-Square Distribution; Cross-Over Studies; Cycl | 2003 |
Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase | 2004 |
The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain.
Topics: Adult; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationshi | 2008 |
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Lactones; Pain; Sulfones | 1999 |
4 other studies available for rofecoxib and Dysmenorrhea
Article | Year |
---|---|
Fixed drug eruption to rofecoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Dysmenorrhea; Erythema; Female; Huma | 2002 |
Second selective COX-2 inhibitor receives marketing approval.
Topics: Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; | 1999 |
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Syste | 2002 |
[New indication for selective COX-2 inhibitors. Now also approve for acute pain].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug A | 2002 |